Abstract:Background: Bacterial resistance to antibiotic therapies is increasing and new treatment options are badly needed. There is an overlap between these resistant bacteria and organisms classified as likely bioterror weapons. For example, Bacillus anthracis is innately resistant to the anti-folate trimethoprim due to sequence changes found in the dihydrofolate reductase enzyme. Development of new inhibitors provides an opportunity to enhance the current arsenal of anti-folate antibiotics while also expanding the coverage of the anti-folate class. Methods: We have characterized inhibitors of B. anthracis dihydrofolate reductase by measuring the K(i) and MIC values and calculating the energetics of binding. This series contains a core diaminopyrimidine ring, a central dimethoxybenzyl ring, and a dihydrophthalazine moiety. We have altered the chemical groups extended from a chiral center on the dihydropyridazine ring of the phthalazine moiety. The interactions for the most potent compounds were visualized by X-ray structure determination. Results: We find that the potency of individual enantiomers is divergent with clear preference for the S-enantiomer, while maintaining a high conservation of contacts within the binding site. The preference for enantiomers seems to be predicated largely by differential interactions with protein residues Leu29, Gln30 and Arg53. Conclusions: These studies have clarified the activity of modifications and of individual enantiomers, and highlighted the role of the less-active R-enantiomer in effectively diluting the more active S-enantiomer in racemic solutions. This directly contributes to the development of new antimicrobials, combating trimethoprim resistance, and treatment options for potential bioterrorism agents.

Virtual screening of LPXTG competitive SrtA inhibitors targeting signal transduction mechanism in Bacillus anthracis: a combined experimental and theoretical study

Interrogation of Bacillus Anthracis SrtA Active Site Loop Forming Open/close Lid Conformations Through Extensive MD Simulations for Understanding Binding Selectivity of SrtA Inhibitors.

Molecular Insights on exquisitely Selective SrtA inhibitors towards active site loop forming open/close lid conformations in SrtA from Bacillus anthracis

In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. aureus Biofilm Formation

The Complete Assessment of Small Molecule and Peptidomimetic Inhibitors of Sortase A Towards Antivirulence Treatment

Synthesis, Biological Evaluation and Molecular Docking Analysis of 2-Phenyl-benzofuran-3-carboxamide Derivatives As Potential Inhibitors of Staphylococcus Aureus Sortase A

Biological and Biophysical Methods for Evaluation of Inhibitors of Sortase A in Staphylococcus aureus: An Overview

Novel Inhibitor Discovery of Staphylococcus Aureus Sortase B and the Mechanism Confirmation Via Molecular Modeling.

Structure-Guided Design, Synthesis, and Antivirulence Assessment of Covalent Staphylococcus aureus Sortase A Inhibitors

Virtual Screening for Potential Inhibitors of CTX-M-15 Protein of Klebsiella pneumoniae

Virtual Screening of Novel Non-Lactam Inhibitors Against CTX-M-15 β-Lactamase for Enhancement and Remodeling of Antibiotic Efficiency

Antiinfective Therapy with a Small Molecule Inhibitor of Staphylococcus Aureus Sortase.

The Discovery of Novel Agents Against Staphylococcus Aureus by Targeting Sortase A: A Combination of Virtual Screening and Experimental Validation.

Prospecting Potential Inhibitors of Sortase A from Enterococcus faecalis: A Multidrug Resistant Bacteria, through In-silico and In-vitro Approaches

Anti-MRSA drug discovery by ligand-based virtual screening and biological evaluation

Redefining Antibacterial Strategies with computational Screening of Benzimidazole Ligands Against VanZ Protein for Alternatives of Antibiotic.

Insight into the Dual Inhibitory Mechanism of Verbascoside Targeting Serine/threonine Phosphatase Stp1 Against Staphylococcus Aureus.

Discovery of Sortase A Covalent Inhibitors with Benzofuranene Cyanide Structures As Potential Antibacterial Agents Against Staphylococcus Aureus.

Evaluating novel synthetic compounds active against Bacillus subtilis and Bacillus cereus spores using Live imaging with SporeTrackerX

The Prediction of LptA and LptC Protein-Protein Interactions and Virtual Screening for Potential Inhibitors

Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase